Agilon Health Soars 21.88% on Analyst Upgrades

On April 8, 2025, Agilon Health's stock surged by 21.88% in pre-market trading, marking a significant rise that has caught the attention of investors and analysts alike.

Bernstein analyst Lance Wilkes maintained a Hold rating on Agilon Health and set a price target of $3.30. This rating reflects the analyst's cautious optimism about the company's future prospects.

In a notable shift, Bernstein upgraded Agilon Health to Outperform from Market Perform, setting a price target of $8.50. This upgrade indicates increased confidence in the company's performance and potential for growth.

RBC also raised its price target on Agilon Health to $3.50 from $3, while maintaining an Outperform rating. This move suggests that RBC analysts are bullish on the company's future performance.

Sanford C. Bernstein increased their price target on Agilon Health from $2.50 to $3.15, reflecting a positive outlook on the company's prospects. This adjustment comes as part of a series of analyst reports that have been closely monitoring Agilon Health's performance.